Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain

NCT00032097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: motexafin gadolinium
RADIATION: radiation therapy

Sponsor

National Cancer Institute (NCI)